Arrivent BioPharma, Inc. (AVBP)
25.19
+0.22
(+0.88%)
USD |
NASDAQ |
Apr 07, 16:00
25.22
+0.03
(+0.12%)
After-Hours: 20:00
Arrivent BioPharma Market Cap : 1.050B for April 7, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ocugen, Inc. | 564.09M |
| Bristol Myers Squibb Co. | 114.18B |
| ACADIA Pharmaceuticals, Inc. | 3.729B |
| Agenus, Inc. | 168.30M |
| Alnylam Pharmaceuticals, Inc. | 40.97B |
Market Cap Related Metrics
| PEG Ratio | -0.0662 |
| Price to Book Value | 3.419 |
| Price | 25.19 |
| Earnings Yield | -17.53% |
| PEGY Ratio | -0.0662 |